UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 13, 2020
Accession Number:
Submission Type:
CIK: 0001645469
Company Name: Monopar Therapeutics
File Number: 333-235791